6499.TWO
Price:
$48.5
Market Cap:
$4.47B
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in Taiwan and the United States. The company focuses on developing devices for minimally invasive surgeries, such as Duett, a vascular graft system; ClickClean, a solution to view throughout laparoscopic surgeries; AbClose to prevent port site herniation caused by improper closure; UroCross, an expander system; PUMA, a solution to treat orthopedic extremity injuries; and Cross-Seal, a large-bore closure device. It is involved in medical device contract manufacturing, equity investment and commerce of medical devices, manufacturing and sale of injection molding and components of medical ...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2014-12-11
Stock Exchange
TWO
Ticker
6499.TWO
According to Medeon Biodesign, Inc.’s latest financial reports and current stock price. The company's current ROE is -44.14%. This represents a change of 293.62% compared to the average of -11.21% of the last 4 quarters.
The mean historical ROE of Medeon Biodesign, Inc. over the last ten years is -14.86%. The current -44.14% ROE has changed 197.10% with respect to the historical average. Over the past ten years (40 quarters), 6499.TWO's ROE was at its highest in in the December 2022 quarter at -5.13%. The ROE was at its lowest in in the June 2023 quarter at -23.33%.
Average
-14.86%
Median
-12.56%
Minimum
-52.99%
Maximum
50.32%
Discovering the peaks and valleys of Medeon Biodesign, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 330.63%
Maximum Annual ROE = 50.32%
Minimum Annual Increase = -633.88%
Minimum Annual ROE = -52.99%
Year | ROE | Change |
---|---|---|
2024 | -52.99% | 2.05% |
2023 | -51.92% | 330.63% |
2022 | -12.06% | -123.96% |
2021 | 50.32% | -633.88% |
2020 | -9.42% | -27.90% |
The current ROE of Medeon Biodesign, Inc. (6499.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-38.99%
5-year avg
-15.22%
10-year avg
-14.86%
Medeon Biodesign, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medeon Biodesign, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medeon Biodesign, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Medeon Biodesign, Inc.'s ROE?
How is the ROE calculated for Medeon Biodesign, Inc. (6499.TWO)?
What is the highest ROE for Medeon Biodesign, Inc. (6499.TWO)?
What is the 3-year average ROE for Medeon Biodesign, Inc. (6499.TWO)?
What is the 5-year average ROE for Medeon Biodesign, Inc. (6499.TWO)?
How does the current ROE for Medeon Biodesign, Inc. (6499.TWO) compare to its historical average?